SCHEMBL7433406

SCHEMBL7433406

N=C(N)N(CCCc1c[nH]cn1)CCC(c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.37
HRH1 P35367 5/20 0.34
HTR2A P28223 3/20 0.34
CHRM2 P08172 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
HTR1B P28222 1/20 0.33
HRH4 Q9H3N8 2/20 0.32
HRH3 Q9Y5N1 2/20 0.32
SIGMAR1 Q99720 2/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7428983 0.99 PTGDR2 (0.36) PTGDR2HRH1HTR2ACHRM2SLC6A2
SCHEMBL7286799 0.94 SIGMAR1 (0.38) PTGDR2HRH1HTR2ACHRM2SLC6A2
SCHEMBL7285523 0.94 CYP19A1 (0.40) PTGDR2HRH1HTR2ASIGMAR1ALDH1A1
SCHEMBL7285767 0.90 PTGDR2 (0.34) PTGDR2SLC6A2SLC6A4ALDH1A1CYP3A4
SCHEMBL7285350 0.90 CYP19A1 (0.37)
SCHEMBL7295447 0.86 CHRM2 (0.41) HRH1HTR2ACHRM2SLC6A2SLC6A4
SCHEMBL7430483 0.85 SLC6A2 (0.42) HRH1HTR2ACHRM2SLC6A2SLC6A4
SCHEMBL7977296 0.85 PTGDR2 (0.43) PTGDR2HRH1HTR2ACHRM2SLC6A2
SCHEMBL7285697 0.85 CYP19A1 (0.38) LMNACASR
SCHEMBL7295465 0.85 CYP19A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP claimed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP claimed